YAMO PHARMACEUTICALS
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.
YAMO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.yamopharma.com
Total Employee:
1+
Status:
Active
Contact:
1-646-723-2287
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Current Advisors List
Current Employees Featured
Investors List
Autism Impact Fund
Autism Impact Fund investment in Venture Round - Yamo Pharmaceuticals
Official Site Inspections
http://www.yamopharma.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: 192.64.119.168
- IP address: 192.64.119.168
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Yamo Pharmaceuticals"
Company Overview - Yamo Pharma
Yamo Pharmaceuticals is a clinical-stage company dedicated to developing L1-79, an oral treatment targeting core social-interaction deficits in individuals with Autism Spectrum Disorder …See details»
Yamo Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: yamopharma.com : Phone Number: 212 610-1578: Yamo Pharmaceuticals industries Biotech: Headquarters Location: 400 Madison Avenue, New York, NY, 10017 US …See details»
Our Team - Yamo Pharma
Launched 28 products in 15 therapeutic areas ; CEO of Pearl Therapeutics from 2011-2016 which was sold in 2013 to Astra Zeneca for $1.1B.; Previously COO of Pharmaceutical Products at …See details»
Yamo Pharmaceuticals - Crunchbase Company Profile & Funding
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.See details»
Yamo Pharmaceuticals LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Yamo Pharmaceuticals LLC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Yamo Pharmaceuticals - Craft
Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism. The mechanism of action for L1-79 addresses both the central nervous system and …See details»
Yamo Pharmaceuticals - Overview, News & Similar companies
May 14, 2019 Yamo Pharmaceuticals contact info: Phone number: (212) 610-1578 Website: www.yamopharma.com What does Yamo Pharmaceuticals do? Yamo Pharmaceuticals is a …See details»
Yamo Pharmaceuticals LLC - Drug pipelines, Patents, Clinical trials ...
Explore Yamo Pharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 3 news, and 1 literature, Technology Platform:Small molecule drug, Drug:L1 …See details»
Yamo Pharmaceuticals CEO and Key Executive Team | Craft.co
Yamo Pharmaceuticals's Chief Executive Officer is Chuck Bramlage. Other executives include Tom Megerian, Chief Medical Officer & Senior Vice President of Clinical Development; John …See details»
Yamo Pharmaceuticals - PitchBook
Yamo Pharmaceuticals General Information Description. Operator of a therapeutics platform intended to improve the core symptoms of autism spectrum disorder. The company …See details»
General Inquiries - Yamo Pharma
About Us. Company Overview; Our Team; Scientific Advisory Board; Our Technology. Yamo’s Treatment for Autism; About Autism; Information for Patients and CaregiversSee details»
Yamo Pharmaceuticals - LinkedIn
Yamo Pharmaceuticals | 284 followers on LinkedIn. Yamo Pharmaceuticals is developing L1-79, a novel therapy that targets the core symptoms of autism | Yamo Pharmaceuticals is developing …See details»
Yamo Pharmaceuticals LLC Overview - Salary.com
Discover essential details about Yamo Pharmaceuticals LLC, including address, contact, and journey of our company's evolution.See details»
Yamo Pharmaceuticals - Company Profile - Tracxn
Yamo Pharmaceuticals - Developer of therapies to treat autism. Raised funding over 1 round from 1 investor. Yamo Pharmaceuticals has 106 competitors.See details»
Yamo Pharmaceuticals | Ohio Life Sciences
Yamo Pharmaceuticals is developing L1-79, a novel therapy that targets the core symptoms of autism and has been well-tolerated by clinical trial patients to-date.See details»
Team – Page 2 – Yamo Pharmaceuticals
From 2015 to 2017, he was Vice President of Clinical Development followed by Vice President for Medical Affairs at Avanir, building a cutting edge organization and managing a high-functioning …See details»
Yamo Pharmaceuticals | CipherBio
Explore Yamo Pharmaceuticals's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Yamo Pharmaceuticals - Products, Competitors, Financials, …
About Yamo Pharmaceuticals Yamo Pharmaceuticals is a clinical stage pharmaceutical company founded in 2015 to develop L1-79, a novel therapy with the potential to improve the core …See details»
Team - Yamo Pharma
Nov 1, 2018 Senior Vice President – Regulatory Affairs & Quality. Dr. Fischer has 20+ years of experience in regulatory affairs and clinical development; From 2008 to 2017, Dr. Fischer was …See details»